| 000 | 01519 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515033152.0 | ||
| 264 | 0 | _c20070806 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a0004-069X | ||
| 024 | 7 |
_a10.1007/s00005-006-0028-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avon Wenckstern, Henrik | |
| 245 | 0 | 0 |
_aThe role of the lysophospholipid sphingosine 1-phosphate in immune cell biology. _h[electronic resource] |
| 260 |
_bArchivum immunologiae et therapiae experimentalis _c |
||
| 300 |
_a239-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCell Movement _ximmunology |
| 650 | 0 | 4 |
_aDendritic Cells _xdrug effects |
| 650 | 0 | 4 | _aFingolimod Hydrochloride |
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aLymphatic System _xmetabolism |
| 650 | 0 | 4 |
_aLysophospholipids _xbiosynthesis |
| 650 | 0 | 4 |
_aPropylene Glycols _xadverse effects |
| 650 | 0 | 4 |
_aReceptors, Lysosphingolipid _ximmunology |
| 650 | 0 | 4 |
_aSphingosine _xadverse effects |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aZimmermann, Karsten | |
| 700 | 1 | _aKleuser, Burkhard | |
| 773 | 0 |
_tArchivum immunologiae et therapiae experimentalis _gvol. 54 _gno. 4 _gp. 239-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00005-006-0028-9 _zAvailable from publisher's website |
| 999 |
_c16421671 _d16421671 |
||